Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Allan Hackshaw

Showing results (121-130 of 167) with videos related to

Pageof 17
Sort By:
European Journal of Nuclear Medicine and Molecular Imaging|November 2, 2025
Diagnostic performance of quantitative measures from [<sup>18</sup>F]FDG PET/CT, [<sup>18</sup>F]FEC PET/CT, and DW-MRI in the detection of lymph node metastases in endometrial and cervical cancer: data from the MAPPING studyBen G King, Nishat Bharwani, William Wilson, et al.
British Journal of Cancer|November 23, 2016
A national cluster-randomised controlled trial to examine the effect of enhanced reminders on the socioeconomic gradient in uptake in bowel cancer screeningRosalind Raine, Sue M Moss, Christian von Wagner, et al.
Lung Cancer (Amsterdam, Netherlands)|April 29, 2022
The reporting of pulmonary nodule results by letter in a lung cancer screening settingJennifer L Dickson, Amyn Bhamani, Samantha L Quaife, et al.
Lung Cancer (Amsterdam, Netherlands)|January 9, 2023
The SUMMIT Study: Utilising a written 'Next Steps' information booklet to prepare participants for potential lung cancer screening results and follow-upAmyn Bhamani, Carolyn Horst, Fanta Bojang, et al.
Nature Medicine|May 29, 2020
Geospatial immune variability illuminates differential evolution of lung adenocarcinomaKhalid AbdulJabbar, Shan E Ahmed Raza, Rachel Rosenthal, et al.
Nature|March 19, 2026
Thymic health and immunotherapy outcomes in patients with cancerSimon Bernatz, Vasco Prudente, Suraj Pai, et al.
Breast (Edinburgh, Scotland)|October 4, 2022
Concept: A randomised multicentre trial of first line chemotherapy comparing three weekly cabazitaxel versus weekly paclitaxel in HER2 negative metastatic breast cancerAmit Bahl, William Wilson, Jessica Ball, et al.
Nature Cancer|May 15, 2026
Combined ctDNA and serum PSA for dynamic monitoring of metastatic prostate cancer starting first-line treatment: a prospective national cohort studyAnuradha Jayaram, Memuna Rashid, Alison H M Reid, et al.
The New England Journal of Medicine|May 4, 2012
Ablation with low-dose radioiodine and thyrotropin alfa in thyroid cancerUjjal Mallick, Clive Harmer, Beng Yap, et al.
The European Respiratory Journal|September 21, 2019
Sequential screening for lung cancer in a high-risk group: randomised controlled trial: LungSEARCH: a randomised controlled trial of Surveillance using sputum and imaging for the EARly detection of lung Cancer in a High-risk groupStephen G Spiro, Pallav L Shah, Robert C Rintoul, et al.
Pageof 17

Showing results (121-130 of 167) with videos related to

Sort By:
Pageof 17
European Journal of Nuclear Medicine and Molecular Imaging|November 2, 2025
Diagnostic performance of quantitative measures from [<sup>18</sup>F]FDG PET/CT, [<sup>18</sup>F]FEC PET/CT, and DW-MRI in the detection of lymph node metastases in endometrial and cervical cancer: data from the MAPPING studyBen G King, Nishat Bharwani, William Wilson, et al.
British Journal of Cancer|November 23, 2016
A national cluster-randomised controlled trial to examine the effect of enhanced reminders on the socioeconomic gradient in uptake in bowel cancer screeningRosalind Raine, Sue M Moss, Christian von Wagner, et al.
Lung Cancer (Amsterdam, Netherlands)|April 29, 2022
The reporting of pulmonary nodule results by letter in a lung cancer screening settingJennifer L Dickson, Amyn Bhamani, Samantha L Quaife, et al.
Lung Cancer (Amsterdam, Netherlands)|January 9, 2023
The SUMMIT Study: Utilising a written 'Next Steps' information booklet to prepare participants for potential lung cancer screening results and follow-upAmyn Bhamani, Carolyn Horst, Fanta Bojang, et al.
Nature Medicine|May 29, 2020
Geospatial immune variability illuminates differential evolution of lung adenocarcinomaKhalid AbdulJabbar, Shan E Ahmed Raza, Rachel Rosenthal, et al.
Nature|March 19, 2026
Thymic health and immunotherapy outcomes in patients with cancerSimon Bernatz, Vasco Prudente, Suraj Pai, et al.
Breast (Edinburgh, Scotland)|October 4, 2022
Concept: A randomised multicentre trial of first line chemotherapy comparing three weekly cabazitaxel versus weekly paclitaxel in HER2 negative metastatic breast cancerAmit Bahl, William Wilson, Jessica Ball, et al.
Nature Cancer|May 15, 2026
Combined ctDNA and serum PSA for dynamic monitoring of metastatic prostate cancer starting first-line treatment: a prospective national cohort studyAnuradha Jayaram, Memuna Rashid, Alison H M Reid, et al.
The New England Journal of Medicine|May 4, 2012
Ablation with low-dose radioiodine and thyrotropin alfa in thyroid cancerUjjal Mallick, Clive Harmer, Beng Yap, et al.
The European Respiratory Journal|September 21, 2019
Sequential screening for lung cancer in a high-risk group: randomised controlled trial: LungSEARCH: a randomised controlled trial of Surveillance using sputum and imaging for the EARly detection of lung Cancer in a High-risk groupStephen G Spiro, Pallav L Shah, Robert C Rintoul, et al.
Pageof 17